Covishield
-
Covishield could soon be available at medical stores as SII seeks full market authorisation nod
India | Dec 31, 2021, 02:12 PM ISTCovishield has been one of the main Covid-19 vaccines used in India for inoculation. Around 90% population have got Covishield.
-
India total vaccination: 143.83 cr vaccine doses administered till December 30, 2021
India | Dec 30, 2021, 10:45 AM ISTThe Centre has ramped up door-to-door vaccination in order to achieve the target of 100 per cent vaccination of the eligible population who are supposed to receive the jab.
-
CDSCO panel recommends emergency use authorisation for SII’s Covovax
India | Dec 28, 2021, 12:00 AM ISTA CDSCO panel has also recommended restricted emergency use of anti-Covid pill Molnupiravir in India.
-
Over 60% of India's population fully vaccinated against Covid-19
India | Dec 23, 2021, 12:13 PM ISTThe cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 139.70 crore.
-
WHO approves Covovax for emergency use: Adar Poonawalla
India | Dec 17, 2021, 08:53 PM ISTThe DCGI office had granted SII permission to manufacture and stock Covovax on May 17.
-
Vaccine for children aged 3 years and above to be launched in 6 months: Serum Institute
India | Dec 14, 2021, 05:23 PM ISTSpeaking about the Omicron variant, Poonawalla said, "On the back of enough data, it is safe to say that booster vaccine doses are a proven strategy to get antibodies up to a great extent".
-
Expert panel to meet today over Covid booster shot amid Omicron threat
India | Dec 10, 2021, 09:14 AM ISTA booster dose of COVID-19 vaccines, administered months after primary vaccination, is expected to augment immunity against the virus, including neutralizing capacity against the 'variants of concern'.
-
Serum Institute seeks Covishield's booster dose approval from DCGI
India | Dec 01, 2021, 11:56 PM ISTIn an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK's Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca.
-
Will current vaccines remain effective against Omicron? Drugmakers explain
India | Dec 02, 2021, 04:52 PM ISTWith Omicron raising concerns about Covid vaccines' efficacy, drugmakers are stress-testing existing jabs while also racing to prepare new formulas.
-
Serum Institute resumes exports of Covishield vaccine
India | Nov 26, 2021, 06:23 PM ISTThe vaccine maker has cumulatively produced 1.25 billion doses of COVID-19 vaccines so far, a company statement said.
-
Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations
India | Nov 21, 2021, 09:36 PM ISTThe government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar, and Bangladesh under the 'Vaccine Maitri' program.
-
Over 109 crore Covid vaccine doses administered in country so far: Mansukh Mandaviya
India | Nov 09, 2021, 05:24 PM ISTThe Union Health Minister also informed that under 'Har ghar dastak', healthcare workers are going to all houses to carry out the vaccination drive. 96 countries have recognised Covaxin & Covishield. People can see the list via CoWIN app.
-
Serum Institute seeks regular marketing authorisation from DCGI for Covishield
India | Oct 25, 2021, 09:51 PM ISTIf the DCGI grants regular marketing authorisation, Covishield will be the second vaccine in the world to receive such approval. Pfizer-BioNTech's COVID-19 vaccine has received full US FDA approval for use in individuals 16 years of age and older.
-
'I got Covishield from India': President of the 76th UN General Assembly Abdulla Shahid
World | Oct 02, 2021, 02:24 PM ISTThe Covishield vaccine, which has been developed by British-Swedish pharmaceutical company AstraZeneca, is manufactured in India by Pune-based Serum Institute of India.
-
Centre got over 65.25 crore Covishield doses, 9.1 crore Covaxin jabs till September 19
India | Oct 01, 2021, 05:36 PM ISTSII has supplied 20.29 lakh doses of Covishield to Health Ministry in Sept as committed in Aug by Prakash Singh, Director, Govt and Regulatory Affairs at the Pune-based firm.
-
Thane: Man given anti-rabies shot instead of Covid vaccine
India | Sep 29, 2021, 09:37 AM ISTA man in Thane was mistakenly given an anti-rabies shot instead of Covid vaccine at a health centre.
-
COVID-19 vaccine certification for travel must meet ‘minimum criteria’: UK
World | Sep 23, 2021, 05:57 PM ISTTravellers who are not fully vaccinated, or vaccinated in a country such as India currently not on the UK government’s recognised list, must take a pre-departure test, pay for day two and day eight PCR tests after arrival in England and self-isolate for 10 days, with an option to "test to release" after five days following a negative PCR test.
-
Not aware of any concerns being raised by UK: NHA CEO on Covid vaccine certification issue
India | Sep 22, 2021, 09:07 PM ISTIndia had on Tuesday warned of "reciprocal measures" if the UK does not address its concerns over the new travel rules relating to COVID-19 vaccine certification with Foreign Secretary Harsh Vardhan Shringla describing these norms as "discriminatory".
-
After India's strong protest, UK now qualifies Covishield as approved Covid-vaccine
India | Sep 22, 2021, 05:40 PM ISTIndia on Tuesday had warned of "reciprocal measures" if the UK does not address its concerns over the new travel rules relating to COVID-19 vaccine certification with Foreign Secretary Harsh Vardhan Shringla describing these norms as "discriminatory".
-
India raises concern over UK's non-recognition of Covishield, says its ‘discriminating policy’
India | Sep 21, 2021, 09:20 PM ISTOfficial sources said India will take reciprocal measures against travellers from the UK if its concerns are not addressed by October 4 when the new rules will come into effect.